Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001210266 | SCV001381745 | pathogenic | Cranium bifidum occultum | 2019-09-11 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with histidine at codon 148 of the MSX2 protein (p.Pro148His). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and histidine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to segregate with Boston-type craniosynostosis in a family (PMID: 8106171). ClinVar contains an entry for this variant (Variation ID: 16961). This variant has been reported to affect MSX2 protein function (PMID: 9256341, 27013732, 18786927). This variant disrupts the p.Pro148 amino acid residue in MSX2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23949913, 23918290). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000018474 | SCV000038756 | pathogenic | Craniosynostosis 2 | 1996-12-01 | no assertion criteria provided | literature only | |
Gene |
RCV000018474 | SCV000055821 | not provided | Craniosynostosis 2 | no assertion provided | literature only |